[LXRX] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
09-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -27.98%
YoY- -127.99%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 35 37 14 23 234 27 199 -68.70%
PBT -24,587 -23,476 -25,611 -23,122 -18,067 -20,958 -5,495 172.28%
Tax 580 96 -14 -90 19 48 -174 -
NP -25,167 -23,572 -25,611 -23,122 -18,067 -20,958 -5,495 176.55%
Tax Rate - - - - - - - -
Total Cost 25,202 23,609 25,625 23,145 18,301 20,985 5,694 170.30%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -71,905.71 -63,708.11 -182,935.71 -100,530.43 -7,720.94 -77,622.22 -2,761.31 783.80%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.17 -0.16 -0.17 -0.16 -0.13 -0.15 -0.04 163.07%
EPS Diluted -0.17 -0.16 -0.17 -0.16 -0.13 -0.15 -0.04 163.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.